Ru486 Backers Feud Among Themselves

Etienne-Emile Baulieu, the French researcher who developed the RU486 abortion pill, badly wants to broaden its use. And, like some Clinton Administration officials, he is frustrated at drugmaker Roussel Uclaf's slow pace in bringing RU486 to the U.S. The company so far has failed to come to terms with the Population Council, a New York outfit planning to license the drug in the U.S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.